These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 37103974)

  • 1. Venous thromboembolism prophylaxis in sickle cell disease: a multicenter cohort study of adolescent inpatients.
    Davila J; Stanek J; O'Brien SH
    Blood Adv; 2023 May; 7(9):1762-1768. PubMed ID: 37103974
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enoxaparin adherence for venous thromboembolism prophylaxis in hospitalized patients with sickle cell disease.
    Sakon C; Nikirk M; O'Brien ARW
    Expert Rev Hematol; 2023 Feb; 16(2):147-150. PubMed ID: 36576324
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sickle cell disease and venous thromboembolism: what the anticoagulation expert needs to know.
    Naik RP; Streiff MB; Lanzkron S
    J Thromb Thrombolysis; 2013 Apr; 35(3):352-8. PubMed ID: 23435703
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Venous thromboembolism prophylaxis practices for patients with sickle cell disease prior to and during the COVID-19 pandemic.
    Davila J; Mitchell WB; Morrone K; Silver EJ; Minniti CP; Billett HH; Desai PC; O'Brien SH; Manwani D
    Blood Coagul Fibrinolysis; 2023 Dec; 34(8):471-477. PubMed ID: 37756203
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Venous thromboembolism in pediatric patients with sickle cell disease: A north American survey on experience and management approaches of pediatric hematologists.
    Betensky M; Kumar R; Hankins JS; Goldenberg NA;
    Thromb Res; 2022 Mar; 211():133-139. PubMed ID: 35151008
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness and safety of oral anticoagulants in patients with sickle cell disease and venous thromboembolism: a retrospective cohort study.
    Roberts MZ; Gaskill GE; Kanter-Washko J; Kyle TR; Jones BC; Bohm NM
    J Thromb Thrombolysis; 2018 May; 45(4):512-515. PubMed ID: 29556958
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rates of pharmacologic venous thromboembolism prophylaxis in hospitalized patients with active ulcerative colitis: results from a tertiary care center.
    Tinsley A; Naymagon S; Enomoto LM; Hollenbeak CS; Sands BE; Ullman TA
    J Crohns Colitis; 2013 Dec; 7(12):e635-40. PubMed ID: 23706933
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Venous thromboembolism in adults with sickle cell disease: experience of a single centre in the UK.
    van Hamel Parsons V; Gardner K; Patel R; Thein SL
    Ann Hematol; 2016 Jan; 95(2):227-32. PubMed ID: 26490882
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluating the safety and effectiveness of venous thromboembolism prophylaxis in patients with sickle cell disease.
    Kelley D; Jones LT; Wu J; Bohm N
    J Thromb Thrombolysis; 2017 May; 43(4):463-468. PubMed ID: 27943026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. THromboprophylaxis In Sickle Cell Disease with central venous catheters (THIS): an internal pilot randomised controlled trial protocol.
    Abdulrehman J; Forté S; Tomlinson G; Solh Z; Bolster L; Sun HL; Bartolucci P; Kuo KHM
    BMJ Open; 2024 Jan; 14(1):e079363. PubMed ID: 38171625
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence and risk factors for venous thromboembolism in children with sickle cell disease: an administrative database study.
    Kumar R; Stanek J; Creary S; Dunn A; O'Brien SH
    Blood Adv; 2018 Feb; 2(3):285-291. PubMed ID: 29431623
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluating thromboprophylaxis in the sickle cell disease population: Navigating the evidence gap.
    Davila J; O'Brien SH; Mitchell WB; Manwani D
    Br J Haematol; 2024 Jun; 204(6):2184-2193. PubMed ID: 38578212
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Venous Thromboembolism in Children with Sickle Cell Disease: A Retrospective Cohort Study.
    Woods GM; Sharma R; Creary S; O'Brien S; Stanek J; Hor K; Young J; Dunn AL; Kumar R
    J Pediatr; 2018 Jun; 197():186-190.e1. PubMed ID: 29605397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overcoming challenges of venous thromboembolism in sickle cell disease treatment.
    Ogunsile FJ; Naik R; Lanzkron S
    Expert Rev Hematol; 2019 Mar; 12(3):173-182. PubMed ID: 30773073
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unawareness of thromboprophylaxis is associated with low venous thromboembolism occurrence in hospitalized patients with acute inflammatory bowel disease flare.
    Sbeit W; Kadah A; Shafrir A; Kalisky I; Mahamid M; Hazou W; Katz L; Mari A; Khoury T
    Minerva Med; 2020 Dec; 111(6):560-565. PubMed ID: 32729705
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Venous thromboembolism risk assessment and prophylaxis in hospitalised medical patients in the Cape Town metropole, South Africa.
    Wehmeyer A; Coetzee R; McCartney J
    S Afr Med J; 2022 Feb; 112(2):13506. PubMed ID: 35139994
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Venous thromboembolism prophylaxis in hospitalized sickle cell disease and sickle cell trait patients.
    Ionescu F; Anusim N; Zimmer M; Jaiyesimi I
    Eur J Haematol; 2022 Sep; 109(3):282-288. PubMed ID: 35617049
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improved compliance with venous thromboembolism pharmacologic prophylaxis for patients with gynecologic malignancies hospitalized for nonsurgical indications did not reduce venous thromboembolism incidence.
    Prescott LS; Kidin LM; Downs RL; Cleveland DJ; Wilson GL; Munsell MF; DeJesus AY; Cain KE; Ramirez PT; Kroll MH; Levenback CF; Schmeler KM
    Int J Gynecol Cancer; 2015 Jan; 25(1):152-9. PubMed ID: 25365592
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of Direct Oral Anticoagulants in Patients with Sickle Cell Disease and Venous Thromboembolism: A Prospective Cohort Study of 12 Patients.
    Christen JR; Bertolino J; Jean E; Camoin L; Ebbo M; Harlé JR; Schleinitz N; Sarlon G; Bernit E
    Hemoglobin; 2019; 43(4-5):296-299. PubMed ID: 31724442
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Venous thromboembolism and underutilisation of anticoagulant thromboprophylaxis in hospitalised patients with inflammatory bowel disease.
    Dwyer JP; Javed A; Hair CS; Moore GT
    Intern Med J; 2014 Aug; 44(8):779-84. PubMed ID: 24893756
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.